OBJECTIVE: To determine the prevalence of in vitro resistance to metronidaz
ole among unselected isolates of Trichomonas vaginalis and correlate in vit
ro findings with response to metronidazole therapy.
STUDY DESIGN: Vaginal fluid from women attending a gynecology clinic at an
urban hospital was cultured, isolates were tested for in vitro resistance t
o metronidazole, and these results were correlated with therapeutic outcome
.
RESULTS: Among 911 women, T vaginalis was detected by culture in 82 (9.0%).
Of the 82 isolates, 2 (2.4%; 95% CI, 0.3-8.5%) had low-level in vitro resi
stance (minimum lethal concentration, 50 mug/mL). Women with positive wet m
ount examinations were treated with metronidazole, 2 g, once and asked to r
eturn in one week. Of the 42 infected women agreeing to return for a repeat
examination and culture, 26 (61.9%) did, and all (including one woman with
a resistant isolate) were cured.
CONCLUSION: Isolates of T vaginalis resistant to metronidazole occur widely
throughout the United States. Although the in vitro susceptibility of T va
ginalis to metronidazole has been very poorly studied, our study is consist
ent with a decade-old prevalence estimate of in vitro resistance (5%), and
suggests that high-level resistance is uncommon. This study confirmed, in t
he absence of reinfection, the continuing clinical effectiveness of single-
dose metronidazole for the large majority of trichomoniasis cases.